A Norfolk woman died after obesity complicated life-saving treatment for a neurological illness, with a hospital consultant ...

Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? A Mayo Clinic ...

The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were previously out of reach for seniors.

Obesity can act as fuel for leukemia, according to a study led by Indiana University School of Medicine scientists. To help ...

A review suggests that although obesity medications, such as GLP-1 drugs, can result in substantial weight loss, many obesity ...

A new study from researchers at LSU's Pennington Biomedical Research Center, FMOL Health | Our Lady of the Lake Regional ...

People with the highest levels of obesity are undergoing fewer surgical procedures, despite growth in that patient population, a new analysis showed. “We are seeing more patients with severe obesity ...

TORONTO — Health Canada has approved weight-loss drug Zepbound for treating obstructive sleep apnea in adults with obesity.

In an extremely odd case, a single 79-year-old patient was granted early access to Eli Lilly’s powerful, still-experimental obesity drug retatrutide through the Food and Drug Administration’s ...

This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. WASHINGTON — Millions of Americans with ...